Indoco is a fully integrated, research-oriented pharmaceutical company with a strong global presence . The Company’s turnover is US$ 180 million with a human capital of 6000 employees, including over 300 skilled scientists and Field.
Indoco develops and manufactures a wide range of pharmaceutical products for the Indian and international markets. It generates more than 106 million prescriptions annually from over 2,43,000 doctors belonging to various specialties.
The Company’s R&D team develops non-infringing processes for APIs, formulations and various dosage forms like Immediate Release Tablets, Capsules, Multi-Unit Pellet Systems (MUPS), PDDS, ER Tablets and nano suspensions, as well as a range of injectable solutions, suspensions and depot based long-acting injectables.
Indoco has 11 domestic marketing divisions with a strong brand portfolio in various therapeutic segments, including Stomatologicals, Gastro-Intestinal, Respiratory, Anti-Infectives, Vitamins/Minerals/Nutrients, Cold & Cough, Ophthalmics, Antifungal, Antidiabetic & Cardiovascular, Urology, and several others. Top Indoco brands include Cyclopam, Febrex Plus, Sensodent-K, Karvol Plus, ATM, Oxipod, Cital, Cital UTI, Sensoform, Sensodent-KF, Aloja, Glychek, Kidodent, Tuspel Plus, Subitral, Rexidin, Dropizin, Tuspel LS, MCBM 69, Methycal, Cloben-G, Noxa, Homide, Cal-Aid, Ninaf, Otorex, Macuchek, Mofloren, Irivisc, PGVISC, Nepachek.
Indoco exports a variety of products to regulated and emerging markets, including the USA and EU. The Company has tie-ups with large generic companies and works in close coordination with its customers to leverage core competencies. Indoco’s branded formulations are promoted and distributed across India and in Emerging Markets of South East Asia, Africa, Latin America and CIS.
IAS division is USFDA approved and based at Navi Mumbai. It serves customers for their analytical research needs, utilizing state-of-utilizing state-of-the-art instruments and infrastructure.
Company Details
- Employees
- 4.92K
- Founded
- -
- Address
- Indoco House, 166 Cst Road, Kalina, Santacruz (E), Mumbai,maharashtra 400098,india
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- indoco.com
- Keywords
- Pain Management, Respiratory, Anti-Infectives, Dental Care, Ophthalmic, Anti-Diabetics, cardiology, Stomatologicals, Gynaecology, Vitamin /Mineral /Nutrients, Ophthal / Otological, Chronic & Sub-Chronic, gastrointestinal, Active Pharmaceutcal Ingredients, Finished Dosages, Analytical Services, Clinical Research, Pharmacovigilance Studies, Stability Studies.
- HQ
- Mumbai, Maharashtra
Indoco Remedies Ltd. Questions
Indoco Remedies Ltd.'s website is indoco.com
Indoco Remedies Ltd.'s LinkedIn profile is https://in.linkedin.com/company/indoco-remedies-ltd
Indoco Remedies Ltd. has
4.92K employees.
View email and phone details for 4.92K
employees at Indoco Remedies Ltd..
Indoco Remedies Ltd.'s industry is
Pharmaceutical Manufacturing
Indoco Remedies Ltd.'s top competitors are
Zydus Group,
Piramal Pharma Ltd,
Sun Pharma,
Emcure Pharmaceuticals Limited,
Lupin,
Glenmark Pharmaceuticals,
Intas Pharmaceuticals,
Cipla,
Mankind Pharma Ltd,
Alkem Laboratories Ltd..
Indoco Remedies Ltd.'s categories are Pharmaceutical Manufacturing
Indoco Remedies Ltd.'s founding year is 1947
